The business of editing genes to battle disease is bringing in record funding
Marketplace Tech
English - September 08, 2021 09:26 - 8 minutes - 11.8 MB - ★★★★★ - 1.2K ratingsTechnology Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: El Salvador becomes the first to make bitcoin a national currency
When you’re sick, you can get treated with medicine or surgery. There’s a growing field, though, that looks at our own cells as treatment delivery systems. Many see it as the future of medicine, and that’s prompting a lot of investment in the field. This year, the industry is on track to raise more than $20 billion dollars, a record. That’s according to the Alliance for Regenerative Medicine, an advocacy group whose members include universities, foundations and major biopharma companies like Pfizer, Bayer and Johnson & Johnson. Marketplace’s Jed Kim talks to Janet Lambert, their CEO.